Medpace Financial Ratios
NASDAQ: MEDPHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medpace ratio analysis
Medpace earned a net margin of 17.8% in FY 2025, down from 19.2% a year earlier. Return on equity reached 98.3%, meaning Medpace generated 0.98 dollars of profit for every dollar of shareholders' equity, an unusually high figure that often reflects a small equity base after share buybacks. At the end of FY 2025, MEDP traded at 37.4 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 26.6 to 97.5, with a median of 35.4.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Medpace financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 37.37 | 26.88 | 34.52 | 29.18 | 45.25 | 36.25 | 30.91 | 26.65 | 37.00 | 97.49 |
| Price / sales | 6.51 | 4.98 | 4.99 | 4.71 | 6.83 | 5.36 | 3.44 | 2.65 | 3.25 | 3.05 |
| Price / book | 35.88 | 12.73 | 16.85 | 17.80 | 8.19 | 6.16 | 4.08 | 3.12 | 2.78 | 2.11 |
| Operating margin | 21.1% | 21.2% | 17.9% | 19.1% | 17.4% | 18.0% | 14.8% | 14.3% | 14.9% | 12.5% |
| Net margin | 17.8% | 19.2% | 15.0% | 16.8% | 15.9% | 15.7% | 11.7% | 10.4% | 9.0% | 3.2% |
| Free cash flow margin | 26.9% | 27.1% | 21.0% | 24.1% | 20.6% | 24.6% | 21.4% | 19.9% | 19.6% | 18.5% |
| Return on equity (ROE) | 98.3% | 49.0% | 50.6% | 63.5% | 19.1% | 18.0% | 13.8% | 12.2% | 7.7% | 2.2% |
| Return on assets (ROA) | 22.8% | 19.2% | 17.1% | 18.1% | 11.0% | 10.5% | 8.8% | 7.6% | 4.1% | 1.4% |
| Debt / equity | — | — | 0.00 | 0.13 | 0.00 | — | 0.00 | 0.13 | 0.44 | 0.27 |
| Current ratio | 0.74 | 0.93 | 0.64 | 0.42 | 1.24 | 1.08 | 0.92 | 0.69 | 0.67 | 0.79 |
| Revenue growth | 20.0% | 11.8% | 29.2% | 27.8% | 23.4% | 7.5% | 22.2% | 61.5% | 3.5% | 17.4% |
| EPS growth | 21.0% | 42.2% | 22.0% | 51.4% | 25.3% | 43.8% | 35.5% | 101.0% | 164.9% | — |